{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:02:58Z","timestamp":1791187378772,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.04.070","type":"journal-article","created":{"date-parts":[[2007,5,16]],"date-time":"2007-05-16T08:46:03Z","timestamp":1179305163000},"page":"5945-5957","source":"Crossref","is-referenced-by-count":71,"title":["Do we fully understand the economic value of vaccines?"],"prefix":"10.1016","volume":"25","author":[{"given":"Michael","family":"Drummond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chevat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Lothgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.04.070_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.329.7459.224","article-title":"National Institute for Clinical Excellence and its value judgments","volume":"329","author":"Rawlins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2007.04.070_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/14760584.2.5.649","article-title":"Methodological issues and new developments in the economic evaluation of vaccines","volume":"2","author":"Beutels","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.04.070_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0272989X02239651","article-title":"Economic evaluation of vaccination programs: the impact of herd-immunity","volume":"23","author":"Brisson","year":"2003","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vaccine.2007.04.070_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.070_bib5","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/S0264-410X(03)00377-3","article-title":"The value of vaccination: a global perspective","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.070_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nm0598supp-487","article-title":"Win\u2013win interactions between the public and private sectors","volume":"4","author":"Batson","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.04.070_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/pch\/5.7.371","article-title":"New vaccines and the rising cost of caring","volume":"5","author":"Scheifele","year":"2000","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2007.04.070_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(01)00308-7","article-title":"Priorities among recommended clinical preventive services","volume":"21","author":"Coffield","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2007.04.070_bib9","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.vaccine.2003.10.027","article-title":"The societal value of universal childhood vaccination","volume":"22","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.070_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/14760584.3.4.433","article-title":"Cost-effectiveness studies of pneumococcal conjugate vaccines","volume":"3","author":"McIntosh","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.04.070_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1006\/pmed.2001.0938","article-title":"Comparative cost effectiveness of varicella, hepatitis A, and pneumococcal conjugate vaccines","volume":"33","author":"Jacobs","year":"2001","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2007.04.070_bib12","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/j.vaccine.2004.03.001","article-title":"Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination","volume":"22","author":"Beutels","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.070_bib13","unstructured":"Miller MA, Hinman AR. Economic analyses of vaccine policies. Vaccines. Saunders\/Elsevier; 2004."},{"key":"10.1016\/j.vaccine.2007.04.070_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2165\/00019053-200422110-00003","article-title":"Economic aspects of pneumococcal pneumonia: a review of the literature","volume":"22","author":"De Graeve","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2007.04.070_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14760584.2.4.477","article-title":"Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands","volume":"2","author":"Postma","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.04.070_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1017\/S0266462304001096","article-title":"Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research","volume":"20","author":"Getsios","year":"2004","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vaccine.2007.04.070_bib17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00019053-200523090-00001","article-title":"The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine","volume":"23","author":"Welte","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2007.04.070_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/jhep.2003.50016","article-title":"Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults","volume":"37","author":"Rosenthal","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2007.04.070_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/14760584.2.5.661","article-title":"Hepatitis A and considerations regarding the cost-effectiveness of vaccination programs","volume":"2","author":"Deneke","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.04.070_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2165\/00003495-200262070-00003","article-title":"Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence","volume":"62","author":"Postma","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2007.04.070_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0264-410X(03)00070-7","article-title":"The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines","volume":"21","author":"Nichol","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.070_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0749-3797(00)00151-3","article-title":"Cost-utility analyses of clinical preventive services: published ratios, 1996\u20131997","volume":"19","author":"Stone","year":"2000","journal-title":"Am. J Prev. Med."},{"key":"10.1016\/j.vaccine.2007.04.070_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.publhealth.19.1.125","article-title":"Evaluating the cost-effectiveness of clinical and public health measures","volume":"19","author":"Graham","year":"1998","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.vaccine.2007.04.070_bib24","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2004.05.003","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine in England and Wales","volume":"22","author":"Melegaro","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.070_bib25","series-title":"Health Prevention and Economics","author":"Cohen","year":"1988"},{"key":"10.1016\/j.vaccine.2007.04.070_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2165\/00019053-200422180-00002","article-title":"Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases","volume":"22","author":"Bos","year":"2004","journal-title":"PharmacoEconomics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T21:07:53Z","timestamp":1556399273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":26,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07004987"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}